These findings open up avenues for further exploration of the possible role of amyloid proteins in development of vascular dysfunction in obesity and T2D and the potential of examining BACE1 inhibitor drugs on vascular dysfunction. This evidence concerns the gene BACE1 and obesity due to melanocortin 4 receptor deficiency.